Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 207

1.

Azithromycin to prevent Pseudomonas aeruginosa ventilator-associated pneumonia by inhibition of quorum sensing: a randomized controlled trial.

van Delden C, Köhler T, Brunner-Ferber F, François B, Carlet J, Pechère JC.

Intensive Care Med. 2012 Jul;38(7):1118-25. doi: 10.1007/s00134-012-2559-3. Epub 2012 Apr 20.

PMID:
22527075
2.

Rifampin-bonded vascular grafts and postoperative infections.

Goëau-Brissonnière O, Javerliat I, Koskas F, Coggia M, Pechère JC.

Ann Vasc Surg. 2011 Jan;25(1):134-42. doi: 10.1016/j.avsg.2010.09.002. Review.

PMID:
21172589
3.

Effect of clarithromycin in patients with sepsis and ventilator-associated pneumonia.

Giamarellos-Bourboulis EJ, Pechère JC, Routsi C, Plachouras D, Kollias S, Raftogiannis M, Zervakis D, Baziaka F, Koronaios A, Antonopoulou A, Markaki V, Koutoukas P, Papadomichelakis E, Tsaganos T, Armaganidis A, Koussoulas V, Kotanidou A, Roussos C, Giamarellou H.

Clin Infect Dis. 2008 Apr 15;46(8):1157-64. doi: 10.1086/529439.

PMID:
18444850
4.

A global survey of antibiotic leftovers in the outpatient setting.

Kardas P, Pechère JC, Hughes DA, Cornaglia G.

Int J Antimicrob Agents. 2007 Dec;30(6):530-6. Epub 2007 Oct 22. Erratum in: Int J Antimicrob Agents. 2008 Feb;31(2):188.

PMID:
17933498
5.

Non-compliance with antibiotic therapy for acute community infections: a global survey.

Pechère JC, Hughes D, Kardas P, Cornaglia G.

Int J Antimicrob Agents. 2007 Mar;29(3):245-53. Epub 2007 Jan 16. Review.

PMID:
17229552
6.

Antibiotic policies in surgery: a consensus paper.

Stratchounski LS, Taylor EW, Dellinger EP, Pechere JC.

Int J Antimicrob Agents. 2005 Oct;26(4):312-22. Review. No abstract available.

PMID:
16154725
7.

[The physician, patient and antibiotics].

Pechère JC.

Bull Acad Natl Med. 2004;188(8):1257-65; discussion 1265-7. French.

PMID:
15918656
8.

[How bacteria resist antibiotics: a primary form of collective intelligence?].

Pechère JC.

Bull Acad Natl Med. 2004;188(8):1249-56. Review. French.

PMID:
15918655
9.

Regulatory effects of macrolides on bacterial virulence: potential role as quorum-sensing inhibitors.

Tateda K, Standiford TJ, Pechere JC, Yamaguchi K.

Curr Pharm Des. 2004;10(25):3055-65. Review.

PMID:
15544497
10.

Community-acquired pneumonia: new management strategies for evolving pathogens and antimicrobial susceptibilities.

Klugman KP, Low DE, Metlay J, Pechere JC, Weiss K.

Int J Antimicrob Agents. 2004 Nov;24(5):411-22. Review.

PMID:
15519470
11.

Activities of garenoxacin against quinolone-resistant Streptococcus pneumoniae strains in vitro and in a mouse pneumonia model.

Azoulay-Dupuis E, Bédos JP, Mohler J, Peytavin G, Isturiz R, Moine P, Rieux V, Cherbuliez C, Péchère JC, Fantin B, Köhler T.

Antimicrob Agents Chemother. 2004 Mar;48(3):765-73.

12.

The Pseudomonas aeruginosa autoinducer N-3-oxododecanoyl homoserine lactone accelerates apoptosis in macrophages and neutrophils.

Tateda K, Ishii Y, Horikawa M, Matsumoto T, Miyairi S, Pechere JC, Standiford TJ, Ishiguro M, Yamaguchi K.

Infect Immun. 2003 Oct;71(10):5785-93.

13.

Antibiotic efflux pumps in prokaryotic cells: occurrence, impact on resistance and strategies for the future of antimicrobial therapy.

Van Bambeke F, Glupczynski Y, Plésiat P, Pechère JC, Tulkens PM.

J Antimicrob Chemother. 2003 May;51(5):1055-65. Epub 2003 Apr 14. Review. No abstract available.

PMID:
12697642
14.

Azithromycin reduces the production of virulence factors in Pseudomonas aeruginosa by inhibiting quorum sensing.

Pechère JC.

Jpn J Antibiot. 2001 Dec;54 Suppl C:87-9. Review. No abstract available.

PMID:
12575427
15.

Attitudinal classification of patients receiving antibiotic treatment for mild respiratory tract infections.

Pechère JC, Cenedese C, Müller O, Perez-Gorricho B, Ripoll M, Rossi A, Stahl JP, Stahlmann R, Tramarin A.

Int J Antimicrob Agents. 2002 Dec;20(6):399-406.

PMID:
12458132
16.

The antibacterial activity of topical retinoids: the case of retinaldehyde.

Pechère M, Germanier L, Siegenthaler G, Pechère JC, Saurat JH.

Dermatology. 2002;205(2):153-8.

PMID:
12218231
17.

Amino acid residues essential for function of the MexF efflux pump protein of Pseudomonas aeruginosa.

Aires JR, Pechère JC, Van Delden C, Köhler T.

Antimicrob Agents Chemother. 2002 Jul;46(7):2169-73.

18.

Rotating antibiotics in the intensive care unit: feasible, apparently beneficial, but questions remain.

Pechère JC.

Crit Care. 2002 Feb;6(1):9-10. Epub 2002 Jan 11. No abstract available.

19.

Patterns and modes of beta-lactam resistance in Pseudomonas aeruginosa.

Pechère JC, Köhler T.

Clin Microbiol Infect. 1999 Mar;5 Suppl 1:S15-S18. No abstract available.

20.

Detection of Pseudomonas aeruginosa cell-to-cell signals in lung tissue of cystic fibrosis patients.

Favre-Bonté S, Pache JC, Robert J, Blanc D, Pechère JC, van Delden C.

Microb Pathog. 2002 Mar;32(3):143-7.

PMID:
11855945
21.

Influence of previous exposure to antibiotic therapy on the susceptibility pattern of Pseudomonas aeruginosa bacteremic isolates.

El Amari EB, Chamot E, Auckenthaler R, Pechère JC, Van Delden C.

Clin Infect Dis. 2001 Dec 1;33(11):1859-64. Epub 2001 Oct 24.

PMID:
11692297
22.

Introduction.

Pechère JC.

Int J Antimicrob Agents. 2001;18 Suppl 1:S1-2. No abstract available.

PMID:
11594345
23.

New perspectives on macrolide antibiotics.

Pechère JC.

Int J Antimicrob Agents. 2001;18 Suppl 1:S93-7. Review.

PMID:
11574203
24.

Macrolide resistance mechanisms in Gram-positive cocci.

Pechère JC.

Int J Antimicrob Agents. 2001;18 Suppl 1:S25-8. Review.

PMID:
11574191
25.

Overexpression, refolding, and purification of the histidine-tagged outer membrane efflux protein OprM of Pseudomonas aeruginosa.

Charbonnier F, Köhler T, Pechère JC, Ducruix A.

Protein Expr Purif. 2001 Oct;23(1):121-7.

PMID:
11570853
26.

Experimental treatment of vascular graft infection due to Staphylococcus epidermidis by in situ replacement with a rifampin-bonded polyester graft.

Coggia M, Goëau-Brissonnière O, Leflon V, Nicolas MH, Pechère JC.

Ann Vasc Surg. 2001 Jul;15(4):421-9.

PMID:
11525531
27.

Patients' interviews and misuse of antibiotics.

Pechère JC.

Clin Infect Dis. 2001 Sep 15;33 Suppl 3:S170-3.

PMID:
11524715
28.

Overexpression of the MexEF-OprN multidrug efflux system affects cell-to-cell signaling in Pseudomonas aeruginosa.

Köhler T, van Delden C, Curty LK, Hamzehpour MM, Pechere JC.

J Bacteriol. 2001 Sep;183(18):5213-22.

29.

Azithromycin inhibits quorum sensing in Pseudomonas aeruginosa.

Tateda K, Comte R, Pechere JC, Köhler T, Yamaguchi K, Van Delden C.

Antimicrob Agents Chemother. 2001 Jun;45(6):1930-3.

30.

C-terminal region of Pseudomonas aeruginosa outer membrane porin OprD modulates susceptibility to meropenem.

Epp SF, Köhler T, Plésiat P, Michéa-Hamzehpour M, Frey J, Pechère JC.

Antimicrob Agents Chemother. 2001 Jun;45(6):1780-7.

31.

Genetic background of attenuated Salmonella typhimurium has profound influence on infection and cytokine patterns in human dendritic cells.

Dreher D, Kok M, Cochand L, Kiama SG, Gehr P, Pechère JC, Nicod LP.

J Leukoc Biol. 2001 Apr;69(4):583-9.

PMID:
11310844
32.

Salmonella typhimurium thyA mutants fail to grow intracellularly in vitro and are attenuated in mice.

Kok M, Bühlmann E, Pechère JC.

Microbiology. 2001 Mar;147(Pt 3):727-33.

PMID:
11238980
33.

Bacterial antibiotic efflux systems of medical importance.

Köhler T, Pechère JC, Plésiat P.

Cell Mol Life Sci. 1999 Nov 30;56(9-10):771-8. Review.

PMID:
11212337
34.

New strategies against an old plague: genetically engineered tuberculosis vaccines.

Dreher D, Kok M, Pechère JC, Nicod LP.

Schweiz Med Wochenschr. 2000 Dec 16;130(50):1925-9. Review.

PMID:
11189437
35.

Parameters important in short antibiotic courses.

Pechère JC.

J Int Med Res. 2000;28 Suppl 1:3A-12A. Review.

PMID:
11092225
36.

Swarming of Pseudomonas aeruginosa is dependent on cell-to-cell signaling and requires flagella and pili.

Köhler T, Curty LK, Barja F, van Delden C, Pechère JC.

J Bacteriol. 2000 Nov;182(21):5990-6.

37.

"Chance makes a football of man's life".

Pechère JC, Pittet D.

Infect Control Hosp Epidemiol. 2000 Jun;21(6):365. No abstract available.

PMID:
10879564
38.
39.
40.
41.
42.

Antibacterial activity of retinaldehyde against Propionibacterium acnes.

Pechère M, Pechère JC, Siegenthaler G, Germanier L, Saurat JH.

Dermatology. 1999;199 Suppl 1:29-31.

PMID:
10473957
43.

Carbapenem activities against Pseudomonas aeruginosa: respective contributions of OprD and efflux systems.

Köhler T, Michea-Hamzehpour M, Epp SF, Pechere JC.

Antimicrob Agents Chemother. 1999 Feb;43(2):424-7.

44.

In vivo emergence of multidrug-resistant mutants of Pseudomonas aeruginosa overexpressing the active efflux system MexA-MexB-OprM.

Ziha-Zarifi I, Llanes C, Köhler T, Pechere JC, Plesiat P.

Antimicrob Agents Chemother. 1999 Feb;43(2):287-91.

45.

Bacteriological activity of trovafloxacin, a new quinolone, against respiratory tract pathogens.

Pechère JC, Gootz TD.

Eur J Clin Microbiol Infect Dis. 1998 Jun;17(6):405-12. Review.

PMID:
9758283
46.

Prevention: toward a golden age.

Pechère JC.

Infect Control Hosp Epidemiol. 1998 Aug;19(8):537-8. No abstract available.

PMID:
9758051
47.

[Antibiotic efflux, a mechanism of multiple resistance in Pseudomonas aeruginosa].

Pechère JC, Michéa-Hamzhepour M, Köhler T.

Bull Acad Natl Med. 1998;182(3):599-612; discussion 613-5. Review. French.

PMID:
9673055
48.

Treatment of vascular graft infection by in situ replacement with cryopreserved aortic allografts: an experimental study.

Knosalla C, Goëau-Brissonnière O, Leflon V, Bruneval P, Eugène M, Pechère JC, Koskas F, Nicolas MH, Leschi JP, Gerota J, Kieffer E.

J Vasc Surg. 1998 Apr;27(4):689-98.

49.

Metabolic-cytokine responses to a second immunological challenge with LPS in mice with T. gondii infection.

Arsenijevic D, Girardier L, Seydoux J, Pechere JC, Garcia I, Lucas R, Chang HR, Dulloo AG.

Am J Physiol. 1998 Mar;274(3):E439-45. doi: 10.1152/ajpendo.1998.274.3.E439.

PMID:
9530126
50.

Differential selection of multidrug efflux systems by quinolones in Pseudomonas aeruginosa.

Köhler T, Michea-Hamzehpour M, Plesiat P, Kahr AL, Pechere JC.

Antimicrob Agents Chemother. 1997 Nov;41(11):2540-3.

Supplemental Content

Loading ...
Support Center